Featured Research

from universities, journals, and other organizations

Linezolid Is Highly Effective Against Antibiotic-Resistant Infections

Date:
August 17, 1999
Source:
Northwestern University
Summary:
A study by researchers at Northwestern University Medical School and Northwestern Memorial Hospital reports that linezolid, a new antibiotic, is highly effective against a range of gram-positive bacteria, including several antibiotic-resistant enterococci and staphylococci.

Gram-positive bacterial infections are on the rise, as are the number of new strains of bacteria that are increasingly resistant to antibiotics. For patients infected with these drug-resistant organisms, there are few, if any, therapeutic options.

Now, a study by researchers at Northwestern University Medical School and Northwestern Memorial Hospital reports that linezolid, a new antibiotic, is highly effective against a range of gram-positive bacteria, including several antibiotic-resistant enterococci and staphylococci.

The study, which appears in the August issue of the journal Antimicrobial Agents and Chemotherapy, describes the largest laboratory experience to date with linezolid.

Infectious disease specialist Gary A. Noskin, M.D., and co-researchers from Northwestern compared the activity of linezolid with that of a number of currently available antibiotics against approximately 4,000 fresh bacteria isolates of streptococci, enterococci and staphylococci.

They found that linezolid showed potent activity against all isolates tested and was the most active antibiotic against oxacillin-resistant staphylococci and vancomycin-resistant enterococci, including both VanA or VanB types. Against all vancomycin-susceptible bacteria, the activity of linezolid was comparable to that of vancomycin.

Based on these in vitro results, as well as his clinical experience with this drug, Noskin commented: "Linezolid appears to be a promising new antibiotic for the treatment of a wide range of gram-positive infections, including vancomycin-resistant enterococci."

Noskin is an associate professor of medicine at the Medical School and medical director of Infection Control and Prevention at Northwestern Memorial Hospital. His co-authors on this study were Farida Siddiqui, Valentina Stosor, M.D., Donna Hacek and Lance R. Peterson, M.D., professor of pathology, Northwestern University Medical School.


Story Source:

The above story is based on materials provided by Northwestern University. Note: Materials may be edited for content and length.


Cite This Page:

Northwestern University. "Linezolid Is Highly Effective Against Antibiotic-Resistant Infections." ScienceDaily. ScienceDaily, 17 August 1999. <www.sciencedaily.com/releases/1999/08/990817065229.htm>.
Northwestern University. (1999, August 17). Linezolid Is Highly Effective Against Antibiotic-Resistant Infections. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/1999/08/990817065229.htm
Northwestern University. "Linezolid Is Highly Effective Against Antibiotic-Resistant Infections." ScienceDaily. www.sciencedaily.com/releases/1999/08/990817065229.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins